US Financial 15 Split Corp. Preferred Dividend Declared
TORONTO, March 18, 2024 (GLOBE NEWSWIRE) -- US Financial 15 Split Corp ("US Financial 15") declares its monthly distribution of $0.05292 for each Preferred share, or 10.00% annually based on the previous month end net asset value. Distributions are payable April 10, 2024 to shareholders on record as at March 28, 2024.
US Financial 15 invests in a portfolio consisting of 15 U.S. financial services companies as follows: American Express, Bank of America, Bank of New York Mellon Corp., Citigroup, CME Group Inc., Fifth Third Bancorp, The Goldman Sachs Group, J.P. Morgan Chase & Co., Morgan Stanley, PNC Financial Services Group Inc., Regions Financial Corp., State Street Corp., SunTrust Banks, U.S. Bancorp, and Wells Fargo.
The following issues have been halted by CIRO
Company: Drummond Ventures Corp.
TSX-Venture Symbol: DVX.P
All Issues: Yes
Reason: Pending News
Halt Time (ET): 7:40 AM
CIRO can make a decision to impose a temporary suspension (halt) of trading in a...
SelectQuote, Inc. , a leading distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, today announced it will release its fourth quarter and full year 2024 financial results before market open on Friday,...
News Release ? TC Energy Corporation (TC Energy or the Company) today announced the setting of the distribution record date of Sept. 25, 2024 for the previously announced spinoff of TC Energy's Liquids Pipelines business into South Bow Corporation...
Itafos Inc. ("Itafos" or the "Company") announced today that it has entered into an amendment of its existing credit facilities with a syndicate of lenders led by RBC Capital Markets, pursuant to which the Company will refinance its existing $85...
FT Portfolios Canada Co. ("First Trust Canada"), announced today that it has launched units and hedged units of the First Trust SMID Cap Rising Dividend Achievers ETF (the "fund"). Units of the fund will commence trading on Cboe Canada Inc. at market...
Somite Therapeutics, a tech-bio company harnessing big data and AI to pioneer novel cell replacement therapies, and OmniaBio Inc., a technology-driven cell and gene therapy CDMO founded by CCRM, today announced a cell therapy development and...
